A detailed history of Two Sigma Securities, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 67,728 shares of SPRO stock, worth $90,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,728
Holding current value
$90,078
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.27 - $1.8 $86,014 - $121,910
67,728 New
67,728 $88,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.47 $10,301 - $15,142
10,301 New
10,301 $15,000
Q4 2022

Feb 14, 2023

BUY
$1.55 - $2.12 $36,460 - $49,868
23,523 New
23,523 $40,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $46.6M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.